HomeENSC • NASDAQ
add
Ensysce Biosciences Inc
Previous close
$1.42
Day range
$1.35 - $1.45
Year range
$1.26 - $10.96
Market cap
5.05M USD
Avg Volume
297.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 493.10K | -85.58% |
Operating expense | 1.28M | 18.08% |
Net income | -3.73M | -663.51% |
Net profit margin | -756.26 | -4,006.30% |
Earnings per share | -1.29 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.67M | -59.72% |
Total assets | 3.18M | -66.12% |
Total liabilities | 2.30M | -17.83% |
Total equity | 874.71K | — |
Shares outstanding | 3.54M | — |
Price to book | 3.74 | — |
Return on assets | -213.68% | — |
Return on capital | -394.02% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.73M | -663.51% |
Cash from operations | -1.87M | -82.90% |
Cash from investing | -123.64K | — |
Cash from financing | 1.45M | -64.86% |
Net change in cash | -538.36K | -117.31% |
Free cash flow | -725.74K | 52.77% |
About
Founded
2003
Headquarters
Website
Employees
8
